| Type |
Details |
Score |
| HT Experiment |
| Series Id: |
GSE67889 |
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
ArrayExpress |
|
•
•
•
•
•
|
| HT Experiment |
| Series Id: |
E-GEOD-69227 |
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tesone AJ |
| Year: |
2016 |
| Journal: |
Cell Rep |
| Title: |
Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. |
| Volume: |
14 |
| Issue: |
7 |
| Pages: |
1774-1786 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Magnusson JP |
| Year: |
2014 |
| Journal: |
Science |
| Title: |
A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse. |
| Volume: |
346 |
| Issue: |
6206 |
| Pages: |
237-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Canalis E |
| Year: |
2021 |
| Journal: |
J Biol Chem |
| Title: |
Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling. |
|
|
| Pages: |
100583 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
López-López S |
| Year: |
2020 |
| Journal: |
Sci Rep |
| Title: |
NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages. |
| Volume: |
10 |
| Issue: |
1 |
| Pages: |
14839 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rusanescu G |
| Year: |
2014 |
| Journal: |
J Cell Mol Med |
| Title: |
Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord. |
| Volume: |
18 |
| Issue: |
10 |
| Pages: |
2103-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jurynczyk M |
| Year: |
2008 |
| Journal: |
J Immunol |
| Title: |
Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. |
| Volume: |
180 |
| Issue: |
4 |
| Pages: |
2634-40 |
|
•
•
•
•
•
|
| HT Experiment |
| Series Id: |
GSE40527 |
| Experiment Type: |
transcription profiling by array |
| Study Type: |
WT vs. Mutant |
| Source: |
ArrayExpress |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
Baseline |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kramer AC |
| Year: |
2017 |
| Journal: |
Leukemia |
| Title: |
Dnmt3a regulates T-cell development and suppresses T-ALL transformation. |
| Volume: |
31 |
| Issue: |
11 |
| Pages: |
2479-2490 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Verhein KC |
| Year: |
2015 |
| Journal: |
Environ Health Perspect |
| Title: |
Novel Roles for Notch3 and Notch4 Receptors in Gene Expression and Susceptibility to Ozone-Induced Lung Inflammation in Mice. |
| Volume: |
123 |
| Issue: |
8 |
| Pages: |
799-805 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sharma M |
| Year: |
2021 |
| Journal: |
Data Brief |
| Title: |
Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. |
| Volume: |
35 |
|
| Pages: |
106873 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
739
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nam Y |
| Year: |
2006 |
| Journal: |
Cell |
| Title: |
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. |
| Volume: |
124 |
| Issue: |
5 |
| Pages: |
973-83 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kovall RA |
| Year: |
2008 |
| Journal: |
Oncogene |
| Title: |
More complicated than it looks: assembly of Notch pathway transcription complexes. |
| Volume: |
27 |
| Issue: |
38 |
| Pages: |
5099-109 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McElhinny AS |
| Year: |
2008 |
| Journal: |
Oncogene |
| Title: |
Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. |
| Volume: |
27 |
| Issue: |
38 |
| Pages: |
5138-47 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shen H |
| Year: |
2006 |
| Journal: |
Genes Dev |
| Title: |
The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. |
| Volume: |
20 |
| Issue: |
6 |
| Pages: |
675-88 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhao Y |
| Year: |
2007 |
| Journal: |
J Biol Chem |
| Title: |
The notch regulator MAML1 interacts with p53 and functions as a coactivator. |
| Volume: |
282 |
| Issue: |
16 |
| Pages: |
11969-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Alves-Guerra MC |
| Year: |
2007 |
| Journal: |
Cancer Res |
| Title: |
Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. |
| Volume: |
67 |
| Issue: |
18 |
| Pages: |
8690-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiang MY |
| Year: |
2006 |
| Journal: |
Mol Cell Biol |
| Title: |
Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. |
| Volume: |
26 |
| Issue: |
16 |
| Pages: |
6261-71 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu H |
| Year: |
2009 |
| Journal: |
Circ Res |
| Title: |
NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. |
| Volume: |
104 |
| Issue: |
4 |
| Pages: |
466-75 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu L |
| Year: |
2005 |
| Journal: |
EMBO J |
| Title: |
Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. |
| Volume: |
24 |
| Issue: |
13 |
| Pages: |
2391-402 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fryer CJ |
| Year: |
2004 |
| Journal: |
Mol Cell |
| Title: |
Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. |
| Volume: |
16 |
| Issue: |
4 |
| Pages: |
509-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Biehl MJ |
| Year: |
2015 |
| Journal: |
Dev Biol |
| Title: |
Rbpj-κ mediated Notch signaling plays a critical role in development of hypothalamic Kisspeptin neurons. |
| Volume: |
406 |
| Issue: |
2 |
| Pages: |
235-46 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kelley MR |
| Year: |
1987 |
| Journal: |
Cell |
| Title: |
Mutations altering the structure of epidermal growth factor-like coding sequences at the Drosophila Notch locus. |
| Volume: |
51 |
| Issue: |
4 |
| Pages: |
539-48 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lindsell CE |
| Year: |
1995 |
| Journal: |
Cell |
| Title: |
Jagged: a mammalian ligand that activates Notch1. |
| Volume: |
80 |
| Issue: |
6 |
| Pages: |
909-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ren K |
| Year: |
2022 |
| Journal: |
J Autoimmun |
| Title: |
Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J/NR4A1 axis. |
| Volume: |
133 |
|
| Pages: |
102945 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Machado L |
| Year: |
2021 |
| Journal: |
Cell Stem Cell |
| Title: |
Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation. |
| Volume: |
28 |
| Issue: |
6 |
| Pages: |
1125-1135.e7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang C |
| Year: |
2017 |
| Journal: |
Development |
| Title: |
Ascl2 inhibits myogenesis by antagonizing the transcriptional activity of myogenic regulatory factors. |
| Volume: |
144 |
| Issue: |
2 |
| Pages: |
235-247 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Goldberg LB |
| Year: |
2011 |
| Journal: |
Dev Biol |
| Title: |
Persistent expression of activated Notch inhibits corticotrope and melanotrope differentiation and results in dysfunction of the HPA axis. |
| Volume: |
358 |
| Issue: |
1 |
| Pages: |
23-32 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant stock |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu J |
| Year: |
2007 |
| Journal: |
MGI Direct Data Submission |
| Title: |
Constitutive notch signaling in adult transgenic mice inhibits bFGF-induced angiogenesis and blocks ovarian follicle development |
|
|
|
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Hey1/Hey1 Mesp1/Mesp1<+> Tg(CAG-cat,-Notch1)1Ysa/? |
| Background: |
involves: 129S7/SvEvBrd * C3H * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Shh/Shh<+> |
| Background: |
involves: 129S4/SvJaeSor * 129S6/SvEvTac |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre/Esr1*)35.10Dam/? |
| Background: |
involves: 129S4/SvJae * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Neurog3-cre/Esr1*)1Dam/? |
| Background: |
involves: 129S4/SvJae * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Mx1-cre)1Cgn/? |
| Background: |
involves: 129S4/SvJaeSor * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Hes1/Hes1<+> |
| Background: |
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1 |
| Background: |
involves: 129X1/SvJ * C57BL/6 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Wt1-cre)#Jbeb/? |
| Background: |
involves: 129S4/SvJaeSor |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Six2/Six2<+> |
| Background: |
involves: 129S4/SvJaeSor * C57BL/6J |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Neurog3-cre/ERT2)1Able/? |
| Background: |
involves: 129S4/SvJaeSor * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Col1a1-cre)1Kry/? |
| Background: |
involves: 129S4/SvJaeSor * C57BL/6 * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Six3-cre)69Frty/? |
| Background: |
involves: 129S4/SvJaeSor * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
2441
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cappellari O |
| Year: |
2013 |
| Journal: |
Dev Cell |
| Title: |
Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memory. |
| Volume: |
24 |
| Issue: |
6 |
| Pages: |
586-99 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kawai H |
| Year: |
2017 |
| Journal: |
J Neurosci |
| Title: |
Area-Specific Regulation of Quiescent Neural Stem Cells by Notch3 in the Adult Mouse Subependymal Zone. |
| Volume: |
37 |
| Issue: |
49 |
| Pages: |
11867-11880 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
489
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
826
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
585
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
414
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
680
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
443
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
500
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
249
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
414
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fryer CJ |
| Year: |
2002 |
| Journal: |
Genes Dev |
| Title: |
Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. |
| Volume: |
16 |
| Issue: |
11 |
| Pages: |
1397-411 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
The Notch domain is also called the 'DSL' domain or the Lin-12/Notch repeat (LNR). The LNR region is present only in Notch related proteins C-terminal to EGF repeats. The lin-12/Notch proteins act as transmembrane receptors for intercellular signals that specify cell fates during animal development. In response to a ligand, proteolytic cleavages release the intracellular domain of Notch, which then gains access to the nucleus and acts as a transcriptional co-activator []. The LNR region is supposed to negatively regulate the Lin-12/Notch proteins activity. It is a triplication of an around 35-40 amino acids module present on the extracellular part of the protein [, ]. Each module contains six cysteine residues engaged in three disulphide bonds and three conserved aspartate and asparagine residues []. The biochemical characterisation of a recombinantly expressed LIN-12.1 module from the human Notch1 receptor indicate that the disulphide bonds are formed between the firstand fifth, second and fourth, and third and sixth cysteines. The formation of this particular disulphide isomer is favored by the presence of Ca2+,which is also required to maintain the structural integrity of the rLIN-12.1 module. The conserved aspartate and asparagine residues are likely to be important for Ca2+binding, and thereby contribute to the native fold. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Homologous_superfamily |
| Description: |
This entry represents the N-terminal domain found in a family of neurogenic mastermind-like proteins (MAMLs), which act as critical transcriptional co-activators for Notch signaling [, , ]. Notch receptors are cleaved upon ligand engagement and the intracellular domain of Notch shuttles to the nucleus. MAMLs form a functional DNA-binding complex with the cleaved Notch receptor and the transcription factor CSL, thereby regulating transcriptional events that are specific to the Notch pathway. MAML proteins may also play roles as key transcriptional co-activators in other signal transduction pathways as well, including: muscle differentiation and myopathies (MEF2C) [], tumour suppressor pathway (p53) []and colon carcinoma survival (beta-catenin) []. MAML proteins could mediate cross-talk among the various signaling pathways and the diverse activities of the MAML proteins converge to impact normal biological processes and human diseases, including cancers.The N-terminal domain of MAML proteins adopt an elongated kinked helix that wraps around ANK and CSL forming one of the complexes in the build-up of the Notch transcriptional complex for recruiting general transcription factors []. This N-terminal domain is responsible for its interaction with the ankyrin repeat region of the Notch proteins NOTCH1 [], NOTCH2 [], NOTCH3 []and NOTCH4. It forms a DNA-binding complex with Notch proteins and RBPSUH/RBP-J kappa/CBF1, and also binds CREBBP/CBP []and CDK8 []. The C-terminal region is required for transcriptional activation. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This family includes the neurogenic mastermind-like proteins 1-3 (MAML1-3) from chordates, which act as critical transcriptional co-activators for Notch signaling [, ]. Notch receptors are cleaved upon ligand engagement and the intracellular domain of Notch shuttles to the nucleus. MAMLs form a functional DNA-binding complex with the cleaved Notch receptor and the transcription factor CSL, thereby regulating transcriptional events that are specific to the Notch pathway. MAML proteins may also play roles as key transcriptional co-activators in other signal transduction pathways as well, including: muscle differentiation and myopathies (MEF2C) [], tumour suppressor pathway (p53) []and colon carcinoma survival (beta-catenin) []. MAML proteins could mediate cross-talk among the various signaling pathways and the diverse activities of the MAML proteins converge to impact normal biological processes and human diseases, including cancers.They consist of an N-terminal domain which adopt an elongated kinked helix that wraps around ANK and CSL forming one of the complexes in the build-up of the Notch transcriptional complex for recruiting general transcription factors [, ]]. This N-terminal domain is responsible for its interaction with the ankyrin repeat region of the Notch proteins NOTCH1 [], NOTCH2 [], NOTCH3 []and NOTCH4. It forms a DNA-binding complex with Notch proteins and RBPSUH/RBP-J kappa/CBF1, and also binds CREBBP/CBP []and CDK8 []. The C-terminal region is required for transcriptional activation. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the N-terminal domain found in a family of neurogenic mastermind-like proteins (MAMLs), which act as critical transcriptional co-activators for Notch signaling [, , ]. Notch receptors are cleaved upon ligand engagement and the intracellular domain of Notch shuttles to the nucleus. MAMLs form a functional DNA-binding complex with the cleaved Notch receptor and the transcription factor CSL, thereby regulating transcriptional events that are specific to the Notch pathway. MAML proteins may also play roles as key transcriptional co-activators in other signal transduction pathways as well, including: muscle differentiation and myopathies (MEF2C) [], tumour suppressor pathway (p53) []and colon carcinoma survival (beta-catenin) []. MAML proteins could mediate cross-talk among the various signaling pathways and the diverse activities of the MAML proteins converge to impact normal biological processes and human diseases, including cancers.The N-terminal domain of MAML proteins adopt an elongated kinked helix that wraps around ANK and CSL forming one of the complexes in the build-up of the Notch transcriptional complex for recruiting general transcription factors []. This N-terminal domain is responsible for its interaction with the ankyrin repeat region of the Notch proteins NOTCH1 [], NOTCH2 [], NOTCH3 []and NOTCH4. It forms a DNA-binding complex with Notch proteins and RBPSUH/RBP-J kappa/CBF1, and also binds CREBBP/CBP []and CDK8 []. The C-terminal region is required for transcriptional activation. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Homologous_superfamily |
| Description: |
The Notch domain is also called the 'DSL' domain or the Lin-12/Notch repeat (LNR). The LNR region is present only in Notch related proteins C-terminal to EGF repeats. The lin-12/Notch proteins act as transmembrane receptors for intercellular signals that specify cell fates during animal development. In response to a ligand, proteolytic cleavages release the intracellular domain of Notch, which then gains access to the nucleus and acts as a transcriptional co-activator []. The LNR region is supposed to negatively regulate the Lin-12/Notch proteins activity. It is a triplication of an around 35-40 amino acids module present on the extracellular part of the protein [, ]. Each module contains six cysteine residues engaged in three disulphide bonds and three conserved aspartate and asparagine residues []. The biochemical characterisation of a recombinantly expressed LIN-12.1 module from the human Notch1 receptor indicate that the disulphide bonds are formed between the firstand fifth, second and fourth, and third and sixth cysteines. The formation of this particular disulphide isomer is favored by the presence of Ca2+, which is also required to maintain the structural integrity of the rLIN-12.1 module. The conserved aspartate and asparagine residues are likely to be important for Ca2+binding, and thereby contribute to the native fold. |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kitamoto T |
| Year: |
2010 |
| Journal: |
Stem Cells |
| Title: |
Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. |
| Volume: |
28 |
| Issue: |
12 |
| Pages: |
2205-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tang H |
| Year: |
2008 |
| Journal: |
Development |
| Title: |
Notch signaling maintains Leydig progenitor cells in the mouse testis. |
| Volume: |
135 |
| Issue: |
22 |
| Pages: |
3745-53 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McGovern MM |
| Year: |
2018 |
| Journal: |
Front Cell Neurosci |
| Title: |
Spontaneous Hair Cell Regeneration Is Prevented by Increased Notch Signaling in Supporting Cells. |
| Volume: |
12 |
|
| Pages: |
120 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grassmeyer J |
| Year: |
2017 |
| Journal: |
Dev Biol |
| Title: |
Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression. |
| Volume: |
424 |
| Issue: |
1 |
| Pages: |
77-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jeon HM |
| Year: |
2008 |
| Journal: |
Genes Dev |
| Title: |
Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. |
| Volume: |
22 |
| Issue: |
15 |
| Pages: |
2028-33 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Saito T |
| Year: |
2003 |
| Journal: |
Immunity |
| Title: |
Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. |
| Volume: |
18 |
| Issue: |
5 |
| Pages: |
675-85 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mallo M |
| Year: |
1995 |
| Journal: |
Dev Dyn |
| Title: |
Protein characterization and targeted disruption of Grg, a mouse gene related to the groucho transcript of the Drosophila Enhancer of split complex. |
| Volume: |
204 |
| Issue: |
3 |
| Pages: |
338-47 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rathinam C |
| Year: |
2011 |
| Journal: |
Nat Immunol |
| Title: |
The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells. |
| Volume: |
12 |
| Issue: |
5 |
| Pages: |
399-407 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lefort K |
| Year: |
2004 |
| Journal: |
Semin Cancer Biol |
| Title: |
Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. |
| Volume: |
14 |
| Issue: |
5 |
| Pages: |
374-86 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grabher C |
| Year: |
2006 |
| Journal: |
Nat Rev Cancer |
| Title: |
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. |
| Volume: |
6 |
| Issue: |
5 |
| Pages: |
347-59 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mori M |
| Year: |
2015 |
| Journal: |
Development |
| Title: |
Notch3-Jagged signaling controls the pool of undifferentiated airway progenitors. |
| Volume: |
142 |
| Issue: |
2 |
| Pages: |
258-67 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
2412
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tax FE |
| Year: |
1994 |
| Journal: |
Nature |
| Title: |
Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. |
| Volume: |
368 |
| Issue: |
6467 |
| Pages: |
150-4 |
|
•
•
•
•
•
|
| Allele |
| Name: |
notch 4; targeted mutation 1, Tom Gridley |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huang F |
| Year: |
2017 |
| Journal: |
Front Immunol |
| Title: |
miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages. |
| Volume: |
8 |
|
| Pages: |
1327 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jiang Y |
| Year: |
2019 |
| Journal: |
Protein Cell |
| Title: |
Myeloid-specific targeting of Notch ameliorates murine renal fibrosis via reduced infiltration and activation of bone marrow-derived macrophage. |
| Volume: |
10 |
| Issue: |
3 |
| Pages: |
196-210 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin Y |
| Year: |
2018 |
| Journal: |
Front Immunol |
| Title: |
Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression. |
| Volume: |
9 |
|
| Pages: |
1744 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nakamura M |
| Year: |
2015 |
| Journal: |
J Immunol |
| Title: |
A genome-wide analysis identifies a notch-RBP-Jκ-IL-7Rα axis that controls IL-17-producing γδ T cell homeostasis in mice. |
| Volume: |
194 |
| Issue: |
1 |
| Pages: |
243-51 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant stock, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen S |
| Year: |
2013 |
| Journal: |
J Bone Miner Res |
| Title: |
Notch gain of function inhibits chondrocyte differentiation via Rbpj-dependent suppression of Sox9. |
| Volume: |
28 |
| Issue: |
3 |
| Pages: |
649-59 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yanger K |
| Year: |
2013 |
| Journal: |
Genes Dev |
| Title: |
Robust cellular reprogramming occurs spontaneously during liver regeneration. |
| Volume: |
27 |
| Issue: |
7 |
| Pages: |
719-24 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fujimura S |
| Year: |
2010 |
| Journal: |
J Am Soc Nephrol |
| Title: |
Notch2 activation in the embryonic kidney depletes nephron progenitors. |
| Volume: |
21 |
| Issue: |
5 |
| Pages: |
803-10 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maddaluno L |
| Year: |
2013 |
| Journal: |
Nature |
| Title: |
EndMT contributes to the onset and progression of cerebral cavernous malformations. |
| Volume: |
498 |
| Issue: |
7455 |
| Pages: |
492-6 |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 9, Rui Benedito |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Epitope tag, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 8, Rui Benedito |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Epitope tag, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)89.1Dam/? |
| Background: |
involves: 129S4/SvJae * C57BL/6 * ICR |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Nes-cre)1Kln/? Tg(ACTB-NOTCH1)1Shn/? |
| Background: |
B6.Cg-Tg(Nes-cre)1Kln Tg(ACTB-NOTCH1)1Shn |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Actb-NOTCH1)2Shn/? Tg(Nes-cre)1Kln/? |
| Background: |
involves: C57BL/6J * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(ACTB-NOTCH1)1Shn/? Tg(Syn1-cre)671Jxm/? |
| Background: |
involves: C57BL/6J |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(ACTB-NOTCH1)1Shn/? Tg(Nes-cre/Esr1*)4Ynj/? |
| Background: |
involves: C57BL/6 * C57BL/6J |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Mesp1/Mesp1<+> Rbpj/Rbpj Tg(CAG-cat,-Notch1)1Ysa/? |
| Background: |
involves: 129P2/OlaHsd * C3H * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Mesp1/Mesp1<+> Pofut1/Pofut1 Tg(CAG-cat,-Notch1)1Ysa/? |
| Background: |
involves: C3H * C57BL/6 * CBA * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras Tg(Pdx1-cre/Esr1*)35.10Dam/? |
| Background: |
involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras Tg(Cela1-cre/ERT)1Dam/? |
| Background: |
involves: 129S4/SvJae * 129S4/SvJaeSor |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|